Evidence map›Paper›PMID 16575896›Full record

GuidelineAmerican journal of medical genetics. Part A2006

Reporting genetic results in research studies: summary and recommendations of an NHLBI working group.

Ebony B Bookman, Aleisha A Langehorne, John H Eckfeldt, Kathleen C Glass, Gail P Jarvik, Michael Klag, Greg Koski, Arno Motulsky, Benjamin Wilfond, Teri A Manolio and 3 more

Registry-linked trialAbstract readConference ProceedingsGuideline
In one paragraph

Guideline in American journal of medical genetics. Part A, 2006. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01441141 (Exploratory Studies of Psychophysical Pain Phenotyping and Genetic Variability in Sickle Cell Disease), which is not on this map. Cited by 126 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
126citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01441141 completednot on this mapstarted 2012, after this paper: background citation

Exploratory Studies of Psychophysical Pain Phenotyping and Genetic Variability in Sickle Cell Disease

TypeobservationalSponsorNational Heart, Lung, and Blood Institute (NHLBI)Ran2012 to 2020Enrolled67ConditionsGenotype, Pain, Genetic Variation, Quantitative Sensory Testing (QST)
3 · Its place in the literature

Who cites it

126 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Guideline
  2. Guideline
  3. Guideline
  4. Article
  5. Article
  6. Article
  7. Article
  8. Review
  9. Article
  10. Article
  11. Review
  12. Article
  13. Return of results in a global survey of psychiatric genetics researchers: practices, attitudes, and knowledge.Genetics in medicine : official journal of the American College of Medical Genetics · 2021
    Article
  14. Article
  15. Ethical, Legal, and Social Issues (ELSI) in Clinical Genetics Research.Methods in molecular biology (Clifton, N.J.) · 2021
    Article
  16. Review
  17. Article
  18. Article
  19. Psychiatric genomics researchers' perspectives on best practices for returning results to individual participants.Genetics in medicine : official journal of the American College of Medical Genetics · 2020
    Article
  20. Psychiatric genetics researchers' views on offering return of results to individual participants.American journal of medical genetics. Part B, Neuropsychiatric genetics : the official publication of the International Society of Psychiatric Genetics · 2019
    Article

66 more citing papers are in PubMed but not listed here.

4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

13 authors.

Ebony B BookmanDivision of Epidemiology and Clinical Applications, National Heart, Lung, and Blood Institute, Bethesda, Maryland 20892-7934, USA. bookmane@mail.nih.gov
Aleisha A Langehorne
John H Eckfeldt
Kathleen C Glass
Gail P Jarvik
Michael Klag
Greg Koski
Arno Motulsky
Benjamin Wilfond
Teri A Manolio
Richard R Fabsitz
Russell V Luepker
NHLBI Working Group

Funding

Intramural NIH HHS Z99 HG999999
6 · The paper itself

Abstract

Prospective epidemiologic studies aid in identifying genetic variants associated with diseases, health risks, and physiologic traits. These genetic variants may eventually be measured clinically for purposes of diagnosis, prognosis, and treatment. As evidence of the potential clinical value of such information accrues, research studies face growing pressure to report these results to study participants or their physicians, even before sufficient evidence is available to support widespread screening of asymptomatic persons. There is thus a need to begin to develop consensus on whether and when genetic findings should be reported to participants in research studies. The National Heart, Lung, and Blood Institute (NHLBI) convened a Working Group on Reporting Genetic Results in Research Studies to discuss if, when, and how genetic information should be reported to study participants. The Working Group concluded that genetic test results should be reported to study participants when the associated risk for the disease is significant; the disease has important health implications such as premature death or substantial morbidity or has significant reproductive implications; and proven therapeutic or preventive interventions are available. Finally, the Working Group recommended procedures for reporting genetic research results and encouraged increased efforts to create uniform guidelines for this activity.

Indexed as

Biomedical ResearchCardiovascular DiseasesGenetic TestingHumansTruth Disclosure

Identifiers

PMID16575896
PMCPMC2556074

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.